CRESCENT CAPITAL BDC INC (CCAP) Fundamental Analysis & Valuation

NASDAQ:CCAPUS2256551092

Current stock price

12.66 USD
+0.2 (+1.61%)
Last:

This CCAP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CCAP Profitability Analysis

1.1 Basic Checks

  • CCAP had positive earnings in the past year.
  • In the past year CCAP had a positive cash flow from operations.
  • Each year in the past 5 years CCAP has been profitable.
  • CCAP had a positive operating cash flow in 4 of the past 5 years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M -200M

1.2 Ratios

  • CCAP has a Return On Assets of 2.13%. This is comparable to the rest of the industry: CCAP outperforms 47.08% of its industry peers.
  • CCAP has a Return On Equity (4.89%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.43%, CCAP perfoms like the industry average, outperforming 47.08% of the companies in the same industry.
  • CCAP had an Average Return On Invested Capital over the past 3 years of 4.01%. This is below the industry average of 7.19%.
Industry RankSector Rank
ROA 2.13%
ROE 4.89%
ROIC 3.43%
ROA(3y)3.91%
ROA(5y)3.85%
ROE(3y)8.71%
ROE(5y)8.29%
ROIC(3y)4.01%
ROIC(5y)3.76%
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • CCAP has a Profit Margin (20.63%) which is in line with its industry peers.
  • CCAP's Profit Margin has declined in the last couple of years.
  • CCAP has a better Operating Margin (41.01%) than 74.17% of its industry peers.
  • In the last couple of years the Operating Margin of CCAP has declined.
  • CCAP has a Gross Margin (43.45%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CCAP has declined.
Industry RankSector Rank
OM 41.01%
PM (TTM) 20.63%
GM 43.45%
OM growth 3Y-7.21%
OM growth 5Y-8.9%
PM growth 3Y15.81%
PM growth 5Y-21.89%
GM growth 3Y-3.66%
GM growth 5Y-8.9%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1

2. CCAP Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CCAP has less shares outstanding
  • CCAP has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CCAP is higher compared to a year ago.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.31, we must say that CCAP is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CCAP (0.31) is worse than 65.83% of its industry peers.
  • CCAP has a debt to FCF ratio of 11.69. This is a negative value and a sign of low solvency as CCAP would need 11.69 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 11.69, CCAP perfoms like the industry average, outperforming 59.58% of the companies in the same industry.
  • CCAP has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.24, CCAP is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 11.69
Altman-Z 0.31
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.33 indicates that CCAP may have some problems paying its short term obligations.
  • CCAP has a Current ratio of 0.33. This is amonst the worse of the industry: CCAP underperforms 81.67% of its industry peers.
  • A Quick Ratio of 0.33 indicates that CCAP may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.33, CCAP is doing worse than 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2

3. CCAP Growth Analysis

3.1 Past

  • CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.35%.
  • Measured over the past 5 years, CCAP shows a small growth in Earnings Per Share. The EPS has been growing by 0.22% on average per year.
  • CCAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.24%.
  • The Revenue has been growing by 16.76% on average over the past years. This is quite good.
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
Revenue 1Y (TTM)-15.24%
Revenue growth 3Y12.75%
Revenue growth 5Y16.76%
Sales Q2Q%-12.04%

3.2 Future

  • CCAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.37% yearly.
  • Based on estimates for the next years, CCAP will show a decrease in Revenue. The Revenue will decrease by -5.09% on average per year.
EPS Next Y-7.79%
EPS Next 2Y-6.51%
EPS Next 3Y-3.37%
EPS Next 5YN/A
Revenue Next Year-6.44%
Revenue Next 2Y-5.02%
Revenue Next 3Y-5.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

6

4. CCAP Valuation Analysis

4.1 Price/Earnings Ratio

  • CCAP is valuated cheaply with a Price/Earnings ratio of 6.96.
  • Compared to the rest of the industry, the Price/Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 82.08% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.18, CCAP is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 7.54, the valuation of CCAP can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 84.17% of the companies listed in the same industry.
  • CCAP is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.96
Fwd PE 7.54
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CCAP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCAP is cheaper than 82.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.26
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • CCAP's earnings are expected to decrease with -3.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)31.44
EPS Next 2Y-6.51%
EPS Next 3Y-3.37%

5

5. CCAP Dividend Analysis

5.1 Amount

  • CCAP has a Yearly Dividend Yield of 13.63%, which is a nice return.
  • Compared to an average industry Dividend Yield of 6.65, CCAP pays a better dividend. On top of this CCAP pays more dividend than 83.75% of the companies listed in the same industry.
  • CCAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 13.63%

5.2 History

  • The dividend of CCAP has a limited annual growth rate of 1.08%.
  • CCAP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)1.08%
Div Incr Years0
Div Non Decr Years0
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 196.51% of the earnings are spent on dividend by CCAP. This is not a sustainable payout ratio.
  • CCAP's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP196.51%
EPS Next 2Y-6.51%
EPS Next 3Y-3.37%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CCAP Fundamentals: All Metrics, Ratios and Statistics

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (4/13/2026, 4:30:02 PM)

12.66

+0.2 (+1.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-25
Earnings (Next)05-12
Inst Owners59.21%
Inst Owner Change0%
Ins Owners1.17%
Ins Owner Change0.03%
Market Cap468.04M
Revenue(TTM)167.28M
Net Income(TTM)34.51M
Analysts82.86
Price Target15.49 (22.35%)
Short Float %1.24%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 13.63%
Yearly Dividend1.83
Dividend Growth(5Y)1.08%
DP196.51%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.49%
Min EPS beat(2)-4.13%
Max EPS beat(2)1.15%
EPS beat(4)1
Avg EPS beat(4)-5.6%
Min EPS beat(4)-15.91%
Max EPS beat(4)1.15%
EPS beat(8)3
Avg EPS beat(8)0.91%
EPS beat(12)7
Avg EPS beat(12)2.18%
EPS beat(16)9
Avg EPS beat(16)1.81%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-4%
Max Revenue beat(2)-0.16%
Revenue beat(4)0
Avg Revenue beat(4)-3.35%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)-1.44%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)7
Avg Revenue beat(16)-0.01%
PT rev (1m)-3.35%
PT rev (3m)-3.35%
EPS NQ rev (1m)0.63%
EPS NQ rev (3m)0.49%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)-0.65%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 7.54
P/S 2.8
P/FCF 6.26
P/OCF 6.26
P/B 0.66
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)1.82
EY14.38%
EPS(NY)1.68
Fwd EY13.26%
FCF(TTM)2.02
FCFY15.96%
OCF(TTM)2.02
OCFY15.96%
SpS4.52
BVpS19.1
TBVpS19.1
PEG (NY)N/A
PEG (5Y)31.44
Graham Number27.97
Profitability
Industry RankSector Rank
ROA 2.13%
ROE 4.89%
ROCE 4.34%
ROIC 3.43%
ROICexc 3.44%
ROICexgc 3.44%
OM 41.01%
PM (TTM) 20.63%
GM 43.45%
FCFM 44.67%
ROA(3y)3.91%
ROA(5y)3.85%
ROE(3y)8.71%
ROE(5y)8.29%
ROIC(3y)4.01%
ROIC(5y)3.76%
ROICexc(3y)4.03%
ROICexc(5y)3.78%
ROICexgc(3y)4.04%
ROICexgc(5y)3.8%
ROCE(3y)5.07%
ROCE(5y)4.76%
ROICexgc growth 3Y-3.13%
ROICexgc growth 5Y-2.25%
ROICexc growth 3Y-2.88%
ROICexc growth 5Y-2.28%
OM growth 3Y-7.21%
OM growth 5Y-8.9%
PM growth 3Y15.81%
PM growth 5Y-21.89%
GM growth 3Y-3.66%
GM growth 5Y-8.9%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 11.69
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.32
Cash Conversion N/A
Profit Quality 216.53%
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 0.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.54%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
EPS Next Y-7.79%
EPS Next 2Y-6.51%
EPS Next 3Y-3.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.24%
Revenue growth 3Y12.75%
Revenue growth 5Y16.76%
Sales Q2Q%-12.04%
Revenue Next Year-6.44%
Revenue Next 2Y-5.02%
Revenue Next 3Y-5.09%
Revenue Next 5YN/A
EBIT growth 1Y-24.27%
EBIT growth 3Y4.62%
EBIT growth 5Y6.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.85%
FCF growth 3Y38.79%
FCF growth 5YN/A
OCF growth 1Y26.85%
OCF growth 3Y38.79%
OCF growth 5YN/A

CRESCENT CAPITAL BDC INC / CCAP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CRESCENT CAPITAL BDC INC (CCAP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CCAP.


What is the valuation status for CCAP stock?

ChartMill assigns a valuation rating of 6 / 10 to CRESCENT CAPITAL BDC INC (CCAP). This can be considered as Fairly Valued.


How profitable is CRESCENT CAPITAL BDC INC (CCAP) stock?

CRESCENT CAPITAL BDC INC (CCAP) has a profitability rating of 4 / 10.


How financially healthy is CRESCENT CAPITAL BDC INC?

The financial health rating of CRESCENT CAPITAL BDC INC (CCAP) is 1 / 10.


Can you provide the expected EPS growth for CCAP stock?

The Earnings per Share (EPS) of CRESCENT CAPITAL BDC INC (CCAP) is expected to decline by -7.79% in the next year.